AR007369A1 - El uso de derivados carboxilados y un medicamento que contiene uno o mas de dichos derivados - Google Patents
El uso de derivados carboxilados y un medicamento que contiene uno o mas de dichos derivadosInfo
- Publication number
- AR007369A1 AR007369A1 ARP970102373A ARP970102373A AR007369A1 AR 007369 A1 AR007369 A1 AR 007369A1 AR P970102373 A ARP970102373 A AR P970102373A AR P970102373 A ARP970102373 A AR P970102373A AR 007369 A1 AR007369 A1 AR 007369A1
- Authority
- AR
- Argentina
- Prior art keywords
- derivatives
- carboxylated
- product containing
- medicinal product
- amides
- Prior art date
Links
- 229940126601 medicinal product Drugs 0.000 title 1
- 150000001408 amides Chemical class 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 2
- 150000002148 esters Chemical class 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 abstract 1
- 102000004868 N-Methyl-D-Aspartate Receptors Human genes 0.000 abstract 1
- 108090001041 N-Methyl-D-Aspartate Receptors Proteins 0.000 abstract 1
- 208000027418 Wounds and injury Diseases 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 230000006378 damage Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 229930195712 glutamate Natural products 0.000 abstract 1
- 208000014674 injury Diseases 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 210000002569 neuron Anatomy 0.000 abstract 1
- 231100000189 neurotoxic Toxicity 0.000 abstract 1
- 230000002887 neurotoxic effect Effects 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 150000003254 radicals Chemical class 0.000 abstract 1
- 230000000638 stimulation Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Se relaciona con el uso de buckminsterfulerenos carboxilados en el control o el tratamiento de una lesión neurotóxcica. Especificamente se relaciona conel uso de derivados carboxilados de fórmula: C60(C(COOH)2)n (1)en la cual C60 esbuckminster-fu lereno y n es 1-4, así como los ésteres, amidas y salesfarmacéuticamente aceptables de los mismos, para la fabricación de medicamentos destinados al control o al tratamiento de enfermedades causadas por lasespecies de oxígeno deradicales libres, li berados por las neuronas debido a la estimulación por los receptores de NMDA, de glutamato. Además se relaciona conun medicamento que contiene uno o más de dichos derivados de fórmula 1 o ésteres, amidas y salesfarmacéuticamente aceptables de los mismos.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1889996P | 1996-06-03 | 1996-06-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR007369A1 true AR007369A1 (es) | 1999-10-27 |
Family
ID=21790333
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP970102373A AR007369A1 (es) | 1996-06-03 | 1997-06-02 | El uso de derivados carboxilados y un medicamento que contiene uno o mas de dichos derivados |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP0904070B1 (es) |
| JP (1) | JP2000514412A (es) |
| KR (1) | KR20000016238A (es) |
| CN (1) | CN1221340A (es) |
| AR (1) | AR007369A1 (es) |
| AT (1) | ATE190486T1 (es) |
| AU (1) | AU720528B2 (es) |
| BR (1) | BR9709636A (es) |
| CA (1) | CA2255913C (es) |
| DE (1) | DE69701458T2 (es) |
| DK (1) | DK0904070T3 (es) |
| ES (1) | ES2145608T3 (es) |
| GR (1) | GR3033646T3 (es) |
| PT (1) | PT904070E (es) |
| TR (1) | TR199802504T2 (es) |
| WO (1) | WO1997046227A1 (es) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6538153B1 (en) | 2001-09-25 | 2003-03-25 | C Sixty Inc. | Method of synthesis of water soluble fullerene polyacids using a macrocyclic malonate reactant |
| US7145032B2 (en) * | 2002-02-23 | 2006-12-05 | Washington University | Therapeutic malonic acid/acetic acid C60 tri-adducts of buckminsterfullerene and methods related thereto |
| US20030162837A1 (en) * | 2002-02-23 | 2003-08-28 | Dugan Laura L. | Carboxyfullerenes and methods of use thereof |
| CA2518766C (en) | 2003-03-10 | 2012-07-03 | Mitsubishi Corporation | Anti-hepatitis c virus agents and anti-hiv agents |
| CA2521818A1 (en) * | 2003-04-10 | 2004-10-28 | C Sixty, Inc. | Fullerene compositions for ameliorating dermatological conditions |
| US7163956B2 (en) * | 2003-10-10 | 2007-01-16 | C Sixty Inc. | Substituted fullerene compositions and their use as antioxidants |
| WO2006028635A2 (en) * | 2004-09-02 | 2006-03-16 | C Sixty Inc. | Fullerene compositions for ameliorating hearing loss, collateral damage of chemotherapy, or mucositis |
| JP6471288B2 (ja) * | 2014-12-19 | 2019-02-20 | 昭和電工株式会社 | フラーレン組成物、樹脂添加剤および樹脂組成物 |
| TWI704127B (zh) * | 2017-03-16 | 2020-09-11 | 國立臺灣大學 | 富勒烯衍生物及其用途 |
| CN117203156A (zh) * | 2021-03-01 | 2023-12-08 | 赞迪亚制药公司 | 阿尔茨海默病的治疗和方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1996036631A1 (en) * | 1995-05-19 | 1996-11-21 | Sphere Biosystems, Inc. | Multiply-substituted fullerenes and methods for their preparation and characterization |
-
1997
- 1997-05-26 PT PT97927037T patent/PT904070E/pt unknown
- 1997-05-26 CA CA002255913A patent/CA2255913C/en not_active Expired - Lifetime
- 1997-05-26 CN CN97195219A patent/CN1221340A/zh active Pending
- 1997-05-26 ES ES97927037T patent/ES2145608T3/es not_active Expired - Lifetime
- 1997-05-26 KR KR1019980709809A patent/KR20000016238A/ko not_active Ceased
- 1997-05-26 AT AT97927037T patent/ATE190486T1/de not_active IP Right Cessation
- 1997-05-26 JP JP10500167A patent/JP2000514412A/ja active Pending
- 1997-05-26 WO PCT/EP1997/002679 patent/WO1997046227A1/en not_active Ceased
- 1997-05-26 DK DK97927037T patent/DK0904070T3/da active
- 1997-05-26 TR TR1998/02504T patent/TR199802504T2/xx unknown
- 1997-05-26 AU AU31672/97A patent/AU720528B2/en not_active Expired
- 1997-05-26 BR BR9709636A patent/BR9709636A/pt not_active Application Discontinuation
- 1997-05-26 EP EP97927037A patent/EP0904070B1/en not_active Expired - Lifetime
- 1997-05-26 DE DE69701458T patent/DE69701458T2/de not_active Expired - Lifetime
- 1997-06-02 AR ARP970102373A patent/AR007369A1/es not_active Application Discontinuation
-
2000
- 2000-06-12 GR GR20000401333T patent/GR3033646T3/el not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| AU3167297A (en) | 1998-01-05 |
| DE69701458D1 (de) | 2000-04-20 |
| DK0904070T3 (da) | 2000-06-26 |
| CA2255913C (en) | 2007-07-31 |
| ATE190486T1 (de) | 2000-04-15 |
| EP0904070B1 (en) | 2000-03-15 |
| BR9709636A (pt) | 1999-08-10 |
| EP0904070A1 (en) | 1999-03-31 |
| JP2000514412A (ja) | 2000-10-31 |
| GR3033646T3 (en) | 2000-10-31 |
| WO1997046227A1 (en) | 1997-12-11 |
| CN1221340A (zh) | 1999-06-30 |
| ES2145608T3 (es) | 2000-07-01 |
| KR20000016238A (ko) | 2000-03-25 |
| PT904070E (pt) | 2000-08-31 |
| DE69701458T2 (de) | 2000-09-07 |
| TR199802504T2 (xx) | 1999-03-22 |
| CA2255913A1 (en) | 1997-12-11 |
| AU720528B2 (en) | 2000-06-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2086270T5 (es) | Metabolitos de terfenadina y sus isomeros opticamente puros para tratar trastornos alergicos. | |
| ES2152556T3 (es) | Composiciones que contienen derivados del acido hidroperoxieicosatetraenoico y procedimientos de utilizacion en el tratamiento de trastornos de la sequedad ocular. | |
| KR930702022A (ko) | 인슐린의 경구 투여에 의한 타잎 1 당뇨병의 치료 또는 예방법 | |
| MX9301348A (es) | Nuevos compuestos que tienen actividad farmacologica, proceso para su preparacion y composicion farmaceutica que los comprende. | |
| ES2148132T1 (es) | Metodo de activacion de agentes fotosensitivos. | |
| ES2102195T3 (es) | Derivados heterociclicos de acido carbonico que se fijan en receptores de retinoides. | |
| ES2072323T3 (es) | Compuestos de piperidina y su preparacion y empleo. | |
| ES2087916T3 (es) | Derivado de pirimidina biciclico, metodo para producir el mismo, y preparacion farmaceutica que contiene el mismo como ingrediente activo. | |
| MX9307940A (es) | Nuevos derivados de la imidazopiridina, proceso para su preparacion y formulaciones farmaceuticas que los incluyen | |
| ES2096312T3 (es) | Derivado de quinuclidina como antagonista de la sustancia p. | |
| ECSP941122A (es) | Derivados de 5-arilindoles | |
| ES2059607T3 (es) | Compuesto de benzopirano y su utilizacion farmaceutica. | |
| DE69327432D1 (de) | Heilmittel für wunden und hämorrhoiden | |
| ES2156287T3 (es) | Derivados de difenilmetilen piperidina. | |
| AR007369A1 (es) | El uso de derivados carboxilados y un medicamento que contiene uno o mas de dichos derivados | |
| MX9301197A (es) | Derivados de indol. | |
| ES2524369T3 (es) | Unidad de dosificación que incluye un análogo de prostaglandina para el tratamiento del estreñimiento | |
| ES2084339T3 (es) | Tetrahidropiridinas e hidroxipiperidinas sustituidas utiles como agentes para el sistema nervioso central. | |
| KR970025615A (ko) | 암 전이 억제제 | |
| ES2092646T3 (es) | Metanoantracenos como antagonistas de dopamina. | |
| ITRM910002A1 (it) | Uso dell'acetil l-carnitina nel trattamento terapeutico del coma e composizioni farmaceutiche utili in tale trattamento. | |
| AR016382A1 (es) | Uso de un derivado del acido bencil-indazol metoxialcanoico. | |
| AR005102A1 (es) | Compuestos derivados de octahidro-pirrolo [1,2-a]-pirazina 2,7-sustituidos, composiciones farmaceuticas y uso de dichos compuestos para la fabricacion deun medicamento. | |
| AR021086A1 (es) | Omega-amidas de n-arilsulfonil-aminoacidos, un procedimiento para su preparacion, medicamento, uso de dichos compuestos para la preparacion de un medicamento y procedimiento para la preparacion de un medicamento. | |
| ES2111352T3 (es) | Uso de diester fosfato para el tratamiento de enfermedades retinianas. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |